Pipeline

Fermion's strategy is focused on developing differentiated BIC/FIC products for novel targets across Neurology and Autoimmune Disease indications.

Long term strategy involves build a portfolio of IND and clinical pipelines to progress to Phase 1-2 clinical trials while maintaining a portion for eventual commercialization.

Continue to be a key player in globalization by forging partnerships with leading pharmaceutical companies through licensing or co-development.